Paul Sykes
Foot & Ankle Surgery · Houston, TXNPI 1619934486
Payments from drug & device makers
Across 76 payments — averaging $184.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acera Surgical, Inc.$9K
- Paragon 28, Inc.$1K
- Treace Medical Concepts, Inc.$603
- Smith+Nephew$421
- Kerecis Limited$364
- Amgen$355
- plus $2K from 17 others
What the payments were for
- Travel & lodging$9837%
- Food & beverage$4,32231%
- Education$10%
- Other$8,72562%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acera Surgical, Inc. | 4 | $8,916 |
| Paragon 28, Inc. | 4 | $1,445 |
| Treace Medical Concepts, Inc. | 10 | $603 |
| Smith+Nephew | 8 | $421 |
| Kerecis Limited | 2 | $364 |
| Amgen | 3 | $355 |
| Medline Industries LP | 5 | $332 |
| ETS Wound Care LLC | 2 | $266 |
| Melinta Therapeutics, LLC | 4 | $211 |
| In2bones USA, LLC | 1 | $154 |
| Paratek Pharmaceuticals, Inc. | 7 | $152 |
| Linvatec Corporation | 1 | $146 |
| Abbott | 5 | $131 |
| AbbVie | 6 | $128 |
| KCI USA, Inc. | 1 | $83 |
| OVIK Health, LLC | 1 | $74 |
| GRT US Holding, Inc. | 3 | $67 |
| Organogenesis Inc. | 3 | $60 |
| Convatec Inc. | 2 | $38 |
| Harmony Biosciences LLC | 1 | $29 |
| Stryker | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| CPM Medical Consultants, LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Restrata Wound Matrix$8,916
- Product Portfolio$1,357
- Kerecis Omega3 Marigen$1,322
- Kerecis Omega3 SurgiClose$331
- Lapiplasty System$320
- KRYSTEXXA$260
- MIRRAGEN ADVANCED WOUND MATRIX$193
- CoLink$154
- COLINK 2$146
- BioBrace 23mm$146
- ALLOGRAFT TISSUE$146
- Dermatology and Wound Care$124
- Stravix$120
- Grafix$120
- GrafixPL$120
- Santyl$120
- REGRANEX$120
- Oasis$120
- Kimyrsa$117
- 11 Elite Nanomite Programmable Remote He$113
How this compares
$14,031 in reported general payments places this provider in the 75th percentile of 684 foot & ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Monohydrate | 37 | $1,240 |
| Ciclopirox | 19 | $448 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 24 | $403 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $400 |
| Ibuprofen | 22 | $256 |
| Oxycodone Hcl | 22 | $252 |
| Ammonium Lactate | 13 | $244 |
| Celecoxib | 12 | $204 |
| Terbinafine Hcl | 12 | $114 |
| Methylprednisolone | 12 | $98 |
| Pantoprazole Sodium | 25 | $98 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Houston
- Kevin VarnerHouston$1.1M
- Sherman NaglerHouston$602K
- Abdul NurudeenHouston$404K
- Orlando RiveraHouston$384K
- Brian LepowHouston$311K
- William GranberryHouston$155K
- Yueh LeeHouston$95K
- Julie LesterHouston$94K
- Jason AhueroHouston$76K
- Nathaniel AlabiHouston$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.